CUSIP: 02507A101
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / AVANTIS EMERGING
-
Total 13F shares
-
3,101,354
-
Share change
-
+470,538
-
Total reported value
-
$198,328,030
-
Price per share
-
$63.77
-
Number of holders
-
53
-
Value change
-
+$30,024,481
-
Number of buys
-
26
-
Number of sells
-
13
Security key
02507A101
Report period
Q4 2025
Institutions
53
Top holders
10
Reporting periods
Holder history for CUSIP 02507A101
Recent filing periods:
Top shareholders of AVXC - AMERICAN CENTY ETF TR - AVANTIS EMERGING (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AMERICAN CENTY ETF TR - AVANTIS EMERGING (AVXC) as of Q4 2025
As of 31 Dec 2025,
AMERICAN CENTY ETF TR - AVANTIS EMERGING (AVXC) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,101,354 shares.
The largest 10 holders included
AE Wealth Management LLC, Clearwater Capital Advisors, LLC, MERCER GLOBAL ADVISORS INC /ADV, Vestment Financial LLC, Trajan Wealth LLC, Pacific Sage Partners, LLC, Wealthcare Advisory Partners LLC, TOUNJIAN ADVISORY PARTNERS, LLC, Avior Wealth Management, LLC, and Ridgeline Wealth, LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2025 vs Q3 2025 Across Filers
| Investor |
Q3 2025 Shares |
Q4 2025 Shares |
Share Diff |
Share Chg % |
Q3 2025 Value $ |
Q4 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.